» Articles » PMID: 30588477

Sarcoidosis: Patient Treatment Priorities

Overview
Journal ERJ Open Res
Specialty Pulmonary Medicine
Date 2018 Dec 28
PMID 30588477
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

http://ow.ly/DTvt30mQnqc.

Citing Articles

A Snapshot of United States Sarcoidosis Patients and their Perceived Disease Impact: Results of the Sarcoidosis Research Institute Survey.

Obi O, Polite P, Fish K, DeLuca R, Feustel P, Mandis A Lung. 2025; 203(1):31.

PMID: 39841245 PMC: 11754370. DOI: 10.1007/s00408-024-00761-8.


Rheumatic Manifestations of Sarcoidosis.

Day J, Hamann P Diagnostics (Basel). 2025; 14(24.

PMID: 39767202 PMC: 11675675. DOI: 10.3390/diagnostics14242842.


Quality of life, fatigue and markers in sarcoidosis: A section from Turkey.

Bardakci M, Ayhan Albayrak G Sarcoidosis Vasc Diffuse Lung Dis. 2024; 41(4):e2024049.

PMID: 39655588 PMC: 11708957. DOI: 10.36141/svdld.v41i4.15760.


Longitudinal validation of King's Sarcoidosis Questionnaire in a prospective cohort with mild sarcoidosis.

Moller J, Prior T, Hilberg O, Birring S, Bendstrup E ERJ Open Res. 2024; 10(6).

PMID: 39534770 PMC: 11551859. DOI: 10.1183/23120541.00160-2024.


[Position paper of the Austrian Society for Rheumatology and the Austrian Society for Pneumology on the diagnosis and treatment of sarcoidosis 2024].

Sterniste G, Hackner K, Moazedi-Furst F, Grasl M, Idzko M, Shao G Wien Klin Wochenschr. 2024; 136(Suppl 17):669-687.

PMID: 39382646 PMC: 11464578. DOI: 10.1007/s00508-024-02444-z.


References
1.
Hendriks C, Drent M, Kleijn W, Elfferich M, Wijnen P, de Vries J . Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: A prospective follow-up study. Respir Med. 2017; 138S:S24-S30. DOI: 10.1016/j.rmed.2017.11.008. View

2.
Moor C, van Manen M, van Hagen P, Miedema J, van den Toorn L, Gur-Demirel Y . Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners. Lung. 2018; 196(5):569-575. PMC: 6153596. DOI: 10.1007/s00408-018-0144-4. View

3.
Baughman R, Judson M, Wells A . The indications for the treatment of sarcoidosis: Wells Law. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 34(4):280-282. PMC: 7170078. DOI: 10.36141/svdld.v34i4.6957. View

4.
Denning D, Pleuvry A, Cole D . Global burden of chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J. 2012; 41(3):621-6. DOI: 10.1183/09031936.00226911. View

5.
Maier L, Crouser E, Martin 2nd W, Eu J . Executive Summary of the NHLBI Workshop Report: Leveraging Current Scientific Advancements to Understand Sarcoidosis Variability and Improve Outcomes. Ann Am Thorac Soc. 2017; 14(Supplement_6):S415-S420. PMC: 5802571. DOI: 10.1513/AnnalsATS.201707-563OT. View